CAN DYSPLASIA SURVEILLANCE BE BETTER TARGETED BY USING FAECAL CALPROTECTIN MEASUREMENTS IN ULCERATIVE COLITIS?
Anna-Maija Puolanne 1
Sami Qadri 2
Tiina Vesterinen 2
Saara Hiltunen 3
Aaro Mustonen 3
Johanna Arola 3
Kaija-Leena Kolho 3
Martti A. Färkkilä 3
1 Helsinki University Hospital, Helsinki, Finland
2 Minerva Foundation Institute for Medical Research, Helsinki, Finland
3 BCB Medical Ltd., Espoo, Finland
Session
IBD (Posters)
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]